Frontlight ResearchEarly access
Trial site
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer8 trials
- Bladder cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting7 trials
- Completed3 trials
- Lead sponsor
- Hoffmann-La Roche8 trials
- Genentech, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026